This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Diabetes Mellitus and the Control of Cellular Energy Metabolism
joint with Adipogenesis, Obesity and Inflammation
Organizer(s): Silvia Corvera, Bruce M. Spiegelman and Luciano Rossetti
Date: January 21 - 26, 2006
Location: Fairmont Hotel Vancouver, Vancouver, BC, Canada
Sponsored by Novo Nordisk A/S
Summary of Meeting:
The alarming increase in the number of individuals developing Type 2 Diabetes, together with the disproportionately high expense of its treatment, has raised intensive efforts in understanding the physiopathology of this chronic disease and its complications. The application of technologies of gene expression profiling, gene silencing, proteomics and imaging has led to a wealth of new insights and avenues into this disease. New exciting developments relate to the role of mitochondrial function in the pathogenesis of insulin resistance, in the mechanism of action of insulin sensitizers and in the development of diabetic complications. Other important developments relate to the mechanisms of secretion and action of adipocyte-derived factors such as leptin, adiponectin, and inflammatory cytokines in the periphery and in the central nervous system. A goal of this meeting is to bring together scientists working in the fields of insulin action, diabetes pathogenesis and complications with scientists working in areas of mitochondrial biogenesis, energy metabolism and membrane trafficking in the secretory pathway. The meeting will seek to integrate this information with gene and protein databases from humans and model systems such as rodents, yeast, Drosophila and C.elegans. In addition, half the sessions will be held jointly with the ongoing adipogenesis and obesity meeting to maximize information flow between the highly interrelated problems of obesity, cellular energy homeostasis, and insulin resistance. Collaborative efforts between investigators in these areas and those involved in chemistry and therapeutics are envisioned to result from this meeting.
Scholarship Deadline: September 21 2005
Discounted Abstract Deadline: September 21 2005
Abstract Deadline: October 13 2005
Discounted Registration Deadline: November 21 2005
We gratefully acknowledge additional support for this conference from:
Isis Pharmaceuticals, Inc.Novartis Institutes for BioMedical ResearchNovo Nordisk A/S
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1R13 DK074300-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found